AYAlisa Yamasaki

Alisa Yamasaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alisa Yamasaki has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmad R. Sedaghat

    Department of Otolaryngology–Head and Neck Surgery University of Cincinnati College of Medicine Cincinnati Ohio USA

    5 shared publications
  • Stacey T. Gray

    Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A.

    5 shared publications
  • David S. Caradonna

    Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts; Division of Otolaryngology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

    4 shared publications
  • Katie M. Phillips

    Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts; Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

    4 shared publications
  • Lloyd P. Hoehle

    Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts; Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

    4 shared publications
  • Adam P. Campbell

    Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts; Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

    3 shared publications

Latest Publications

  • Patient Recovery and Satisfaction with Perioperative Care After Rhinoplasty

    by Alisa Yamasaki, Chloe Warinner, Robin Lindsay

    Background: Recovery after rhinoplasty is not well characterized in the literature. Objective: To quantify key aspects of patient recovery after rhinoplasty and characterize factors that may impact recovery and overall satisfaction with perioperative care. Methods: Prospective cohort study of rhinoplasty patients undergoing surgery at a tertiary referral center between January 2018 and January 2020, and completed a patient experience questionnaire at first postoperative visit. Results: Fifty-one patients underwent functional septorhinoplasty. Mean age was 37.8 years (standard error [SE] 2.4) with median 36.0 years (range 16–79). Fifty-three percent were female ( n = 27). Patients resumed most daily activities within 4.1 days. Overall satisfaction with perioperative care was high (mean 9.6, SE 0.1), although 29% of patients ( n = 15) wished they had more information regarding surgical care. Patients who did not desire additional information reported higher satisfaction and faster time to activity recovery compared with those who desired additional information. Conclusions: Rhinoplasty patients are able to resume most routine activities within 4.1 days after surgery, although patients desiring additional information about care demonstrate lower satisfaction with perioperative care and slower recovery compared to those who felt well informed.


  • Cognitive and Quality of Life-Related Burdens of Illness in Pediatric Allergic Airway Disease

    by Alisa Yamasaki, Ciersten A. Burks, Neil Bhattacharyya

    Objective To analyze the prevalence of pediatric allergic airway disease (PAA) and recognize its impact on cognitive function, childhood activities, use of early intervention, and missed school days. Study Design Cross-sectional analysis of National Health Interview Survey (NHIS), 2014 to 2017. Setting US households. Subjects and Methods An NHIS survey of US children and responding caregivers was analyzed to determine the prevalence of PAA, including allergic rhinitis and allergic asthma. Associations were determined between the presence of PAA and activities limited by difficulty remembering, limitation in the amount of childhood play, use of special education/early intervention, and number of missed school days in the past 12 months. Multivariate analysis was used to adjust for age, sex, race, ethnicity, and income level. Results An estimated 11.1 million (10.6-11.6 million, 95% confidence interval) children (mean age, 9.9 years; 56.9% male) reported a diagnosis of PAA (15.1% [14.6-15.6%]). Children with PAA missed 4.0 (3.7-4.4) school days per year vs 2.2 (2.1-2.4) days for those without PAA (P < .001, adjusted). PAA was associated with limited daily activities due to difficulty with memory (odds ratio, 1.8 [1.2-2.9]), limitations in childhood play (3.2 [2.2-4.7]), and need for special education/early intervention services (1.6 [1.4-1.8]) after adjusting for age, sex, race, ethnicity, and income level. Conclusion PAA is a common condition and is associated with declines in cognitive function and school attendance as well as increased use of special education/early intervention. Given the significant prevalence and burden of illness of PAA, further attention is needed to ensure timely diagnosis and treatment.


  • Defining Typical Acetaminophen and Narcotic Usage in the Postoperative Rhinoplasty Patient

    by Natalie Justicz, Shekhar K. Gadkaree, Alisa Yamasaki, Robin W. Lindsay

    Objective: To characterize the acetaminophen and narcotic use pattern of the postoperative rhinoplasty patient. To describe a pain level and pain medication usage pattern of the typical post‐rhinoplasty patient and identify demographic considerations.Study Design: Prospective cohort study at a tertiary care center.Methods: Rhinoplasty patients were given standardized perioperative pain instructions and narcotic medication (18 tabs oxycodone) along with a pain medication use survey. Postoperatively, survey and tracking information was collected regarding narcotic and acetaminophen use at their first postoperative appointment. Patients were asked about non‐steroidal anti‐inflammatory drug, aspirin, and chronic opioid use. Narcotic and acetaminophen use along pain levels (1–10) at time of use were recorded by patients at 4‐hour increments postoperatively until their first postoperative visit.Results: Pain medication usage (oxycodone and acetaminophen) peaked on (postoperative day 1) POD1. Pain was significantly higher in younger patients (30 years old or younger), female patients, and primary rhinoplasty patients. Pain was correlated with acetaminophen and oxycodone use for women, and acetaminophen used for men. Autologous rib grafting was not correlated with higher narcotic use.Conclusion: Describing a pain medication usage pattern for the typical post‐rhinoplasty patient provides both patients and clinicians important knowledge of postoperative pain expectations and has the potential to reduce both the amount of narcotic prescribed by providers and the amount of narcotic used by patients.Level of Evidence: 4 (Case Series) Laryngoscope, 131:48–53, 2021


  • Radial Forearm Free Flap for Cochlear Implant Coverage in a Post-Irradiated Field

    by Nicholas A. Dewyer, Rosh K. Sethi, Alisa Yamasaki, Daniel J. Lee

    Objective: To describe a novel use of a radial forearm free flap (RFFF) for soft tissue coverage over a cochlear implant (CI) in a post-irradiated field. Patients: Single patient case report of a woman with a history of radiation therapy for brainstem astrocytoma who suffered from repeated CI extrusion despite tympanomastoid obliteration and locoregional pedicled flap soft tissue coverage. Intervention(s): Sequential bilateral, single-staged revision cochlear implantation with RFFF soft tissue coverage. Main Outcome Measure(s): Postoperative wound healing complications including infection or device extrusion. Results: There have been no further issues with wound healing, infection, or device extrusion with a follow up period of 3 years on one side and 8 months on the second side. Both CIs are functioning well with the flaps being sufficiently thin to allow for the use of typical external processor magnets. Conclusions: A RFFF can be used to provide robust soft tissue coverage over a CI in a post-irradiated field. The RFFF and CI may safely be performed in a single operation.


  • Rare electrosurgical complications in tonsillectomy: Analysis of national adverse event reporting

    by Alisa Yamasaki, Neil Bhattacharyya

    Objectives: To identify U.S. Food and Drug Administration (FDA)‐reported adverse events related to electrosurgical devices during tonsillectomy and characterize the most common devices and patient/provider sequelae.Study Design: Retrospective analysis of FDA database of device‐related adverse events.Methods: Data were extracted from the OpenFDA database for all adverse events reported for electrosurgical devices used in tonsillectomies from January 2008 to December 2017. Adverse events were classified by device, event type, etiology, complication severity, and patient disposition.Results: Six hundred fifty‐two adverse events were identified, with 195 events (30%) leading to known bodily injury to patient/provider. Device failure was the most common adverse event (202 events, 31%), followed by burns in 187 patient (98% of burns) and three provider events (2%). Burn injuries occurred most frequently with coblation devices (78 events, 42% of burns), monopolar electrocautery (48 events, 25%), and electrosurgical generators (23 events, 13%). Burn injuries most commonly occurred in the oral cavity (144 events, 76% of burn events) and were most commonly first‐degree (28 events, 15%). Complications related to burns were managed conservatively for 36% of burn events (68 events), and secondary surgery was rarely required (8 events, 4%). Postoperative bleeding (173 events, 26%; 3 deaths) and intraoperative fire (73 events, 11%) were also reported. Device failures caused significant OR delay or cancellation in 17% of occurrences (35 events).Conclusion: Numerous complications may occur with various devices used during tonsillectomy and can result in significant patient/provider harm and sequelae. Surgeons must understand the nature of such complications to facilitate safe perioperative care and inform preoperative patient discussions.Level of Evidence: NALaryngoscope, 130:1138–1143, 2020


  • Open Access

    Reevaluating a Standardized Sedation Weaning Protocol for Pediatric Laryngotracheal Reconstruction for Continuous Quality Improvement

    by Sarah N. Bowe, C. Alessandra Colaianni, Alisa Yamasaki, Brian M. Cummings, Christopher J. Hartnick

    In the pediatric population, laryngotracheal stenosis continues to remain a considerable health issue.1-3 Laryngotracheal reconstruction (LTR) has evolved to include a variety of techniques for expanding the stenotic airway, including reconstruction with rib cartilage grafting.4,5 With widespread use of open surgical techniques, decannulation rates surpass 90%.3,6 To achieve a successful outcome, the perioperative treatment of these patients requires coordinated, multidisciplinary care.7-11


  • Improvement in nasal obstruction and quality of life after septorhinoplasty and turbinate surgery

    by Alisa Yamasaki, Patricia A. Levesque, Benjamin S. Bleier, Nicolas Y. Busaba, Stacey T. Gray, Eric H. Holbrook, Ahmad R. Sedaghat, Robin W. Lindsay

    Objectives: To evaluate the long‐term impact of functional septorhinoplasty (SRP) with and without inferior turbinate reduction (ITR) on disease‐specific symptom severity and general health‐related quality of life (QOL).Study Design: Prospective cohort study at a tertiary referral center.Methods: Patients undergoing functional SRP with and without ITR were administered the Nasal Obstruction Symptom Evaluation (NOSE) scale to assess severity of nasal obstruction and the EuroQol‐5 Dimension Questionnaire Visual Analog Scale (EQ‐5D VAS) to assess general health‐related QOL preoperatively and at 2, 4, 6, 12, 24, and 36 months postoperatively. Patient demographics, surgical technique, symptom severity, and QOL outcomes were analyzed.Results: A total of 567 patients were included, with 391 patients undergoing functional SRP alone (54.0% female; mean age 36.0 years [standard deviation (SD):16.2]) and 176 patients undergoing functional SRP with ITR (50.0% female; mean age 35.6 years [SD:13.6]). There was a significant decrease in NOSE and increase in EQ‐5D VAS scores in both groups through at least 24 months postoperatively. Change in NOSE scores was negatively correlated with change in EQ‐5D VAS (r = −0.38, P < 0.01). Compared to patients undergoing SRP, patients also undergoing ITR had a statistically but nonclinically significant improvement in NOSE, with similar trends for EQ‐5D VAS that were not significant.Conclusion: SRP results in a sustained, long‐term improvement in nasal obstruction based on disease‐specific and general health‐related QOL measures, with incremental improvement in outcomes with addition of ITR. This study provides the foundation for defining health outcomes and the health utility value of surgical interventions that address nasal obstruction.Level of Evidence: 2cLaryngoscope, 129:1554–1560, 2019


  • Open Access

    Excision of large cervical lymphatic malformations using a selective neck dissection approach

    by Alisa Yamasaki, Joseph Zenga, Daniel G. Deschler

  • Cockroach hypersensitivity is associated with greater severity of chronic rhinosinusitis

    by Alisa Yamasaki, Lloyd P. Hoehle, Katie M. Phillips, Adam P. Campbell, David S. Caradonna, Stacey T. Gray, Ahmad R. Sedaghat


  • Top Cited Papers

    A validated model for the 22‐item Sino‐Nasal Outcome Test subdomain structure in chronic rhinosinusitis

    by Allen L. Feng, Nicholas C. Wesely, Lloyd P. Hoehle, Katie M. Phillips, Alisa Yamasaki, Adam P. Campbell, Luciano L. Gregorio, Thomas E. Killeen, David S. Caradonna, Josh C. Meier, et al.

    Background: Previous studies have identified subdomains of the 22‐item Sino‐Nasal Outcome Test (SNOT‐22), reflecting distinct and largely independent categories of chronic rhinosinusitis (CRS) symptoms. However, no study has validated the subdomain structure of the SNOT‐22. This study aims to validate the existence of underlying symptom subdomains of the SNOT‐22 using confirmatory factor analysis (CFA) and to develop a subdomain model that practitioners and researchers can use to describe CRS symptomatology.Methods: A total of 800 patients with CRS were included into this cross‐sectional study (400 CRS patients from Boston, MA, and 400 CRS patients from Reno, NV). Their SNOT‐22 responses were analyzed using exploratory factor analysis (EFA) to determine the number of symptom subdomains. A CFA was performed to develop a validated measurement model for the underlying SNOT‐22 subdomains along with various tests of validity and goodness of fit.Results: EFA demonstrated 4 distinct factors reflecting: sleep, nasal, otologic/facial pain, and emotional symptoms (Cronbach's alpha, >0.7; Bartlett's test of sphericity, p < 0.001; Kaiser‐Meyer‐Olkin >0.90), independent of geographic locale. The corresponding CFA measurement model demonstrated excellent measures of fit (root mean square error of approximation, 0.95) and measures of construct validity (heterotrait‐monotrait [HTMT] ratio, 0.7), again independent of geographic locale.Conclusion: The use of the 4‐subdomain structure for SNOT‐22 (reflecting sleep, nasal, otologic/facial pain, and emotional symptoms of CRS) was validated as the most appropriate to calculate SNOT‐22 subdomain scores for patients from different geographic regions using CFA.